194 related articles for article (PubMed ID: 32309339)
1. The combination of preoperative D-dimer and CA19-9 predicts lymph node metastasis and survival in intrahepatic cholangiocarcinoma patients after curative resection.
Chen Q; Zheng Y; Zhao H; Cai J; Wang L; Zhao J; Bi X; Li Z; Huang Z; Zhang Y; Zhou J; Wu J
Ann Transl Med; 2020 Mar; 8(5):192. PubMed ID: 32309339
[TBL] [Abstract][Full Text] [Related]
2. A novel prognostic system combining carbonic anhydrase II and preoperative CA19-9 for intrahepatic cholangiocarcinoma after curative resection.
Zhang J; Huang Q; Yang Y; Zhang J; Fang X; Yang Y; Liang H; Wang W; Wang Y
Cancer; 2023 Apr; 129(7):1030-1040. PubMed ID: 36625486
[TBL] [Abstract][Full Text] [Related]
3. Systemic inflammation score predicts survival in patients with intrahepatic cholangiocarcinoma undergoing curative resection.
Zhang Y; Shi SM; Yang H; Yang LX; Wang Z; Li XD; Yin D; Shi YH; Cao Y; Dai Z; Zhou J; Chen Q
J Cancer; 2019; 10(2):494-503. PubMed ID: 30719145
[TBL] [Abstract][Full Text] [Related]
4. Number and Station of Lymph Node Metastasis After Curative-intent Resection of Intrahepatic Cholangiocarcinoma Impact Prognosis.
Zhang XF; Xue F; Dong DH; Weiss M; Popescu I; Marques HP; Aldrighetti L; Maithel SK; Pulitano C; Bauer TW; Shen F; Poultsides GA; Soubrane O; Martel G; Koerkamp BG; Itaru E; Lv Y; Pawlik TM
Ann Surg; 2021 Dec; 274(6):e1187-e1195. PubMed ID: 31972643
[TBL] [Abstract][Full Text] [Related]
5. Surgical Indication for Advanced Intrahepatic Cholangiocarcinoma According to the Optimal Preoperative Carbohydrate Antigen 19-9 Cutoff Value.
Yamamoto Y; Sugiura T; Todaka A; Okamura Y; Ito T; Ashida R; Kakuda Y; Nakanuma Y; Uesaka K
World J Surg; 2018 Oct; 42(10):3331-3340. PubMed ID: 29619514
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of preoperative CA19-9 and lymph node metastasis in intrahepatic cholangiocarcinoma.
Asaoka T; Kobayashi S; Hanaki T; Iwagami Y; Tomimaru Y; Akita H; Noda T; Gotoh K; Takeda Y; Tanemura M; Doki Y; Eguchi H
Surg Today; 2020 Oct; 50(10):1176-1186. PubMed ID: 32221659
[TBL] [Abstract][Full Text] [Related]
7. Prognostic impact of portal area inflammation on intrahepatic cholangiocarcinoma patients without lymph node metastasis.
Feng X; Chen W; Tao R; Yuan J; Ruan M; Du J; Guo X; Liu F; Liu H
J Gastrointest Oncol; 2023 Oct; 14(5):2229-2242. PubMed ID: 37969826
[TBL] [Abstract][Full Text] [Related]
8. Impact of serum carbohydrate antigen 19-9 level on prognosis and prediction of lymph node metastasis in patients with intrahepatic cholangiocarcinoma.
Yamada T; Nakanishi Y; Okamura K; Tsuchikawa T; Nakamura T; Noji T; Asano T; Tanaka K; Kurashima Y; Ebihara Y; Murakami S; Shichinohe T; Mitsuhashi T; Hirano S
J Gastroenterol Hepatol; 2018 Feb; ():. PubMed ID: 29427472
[TBL] [Abstract][Full Text] [Related]
9. Importance of Normalization of Carbohydrate Antigen 19-9 in Patients With Intrahepatic Cholangiocarcinoma.
Li H; Feng Y; Liu C; Li J; Li J; Wu H; Wang G; Li D
Front Oncol; 2021; 11():780455. PubMed ID: 35004301
[TBL] [Abstract][Full Text] [Related]
10. Intrahepatic cholangiocarcinoma patients without indications of lymph node metastasis not benefit from lymph node dissection.
Hu J; Chen FY; Zhou KQ; Zhou C; Cao Y; Sun HC; Fan J; Zhou J; Wang Z
Oncotarget; 2017 Dec; 8(69):113817-113827. PubMed ID: 29371948
[TBL] [Abstract][Full Text] [Related]
11. Predictive score for identifying intrahepatic cholangiocarcinoma patients without lymph node metastasis: a basis for omitting lymph node dissection.
Miura Y; Ashida R; Ohgi K; Yamada M; Kato Y; Otsuka S; Aramaki T; Kakuda Y; Uesaka K; Sugiura T
HPB (Oxford); 2024 Feb; ():. PubMed ID: 38461071
[TBL] [Abstract][Full Text] [Related]
12. Lymph Node Examination and Patterns of Nodal Metastasis Among Patients with Left- Versus Right-Sided Intrahepatic Cholangiocarcinoma After Major Curative-Intent Resection.
Zhang XF; Xue F; Weiss M; Popescu I; Marques HP; Aldrighetti L; Maithel SK; Pulitano C; Bauer TW; Shen F; Poultsides GA; Cauchy F; Martel G; Koerkamp BG; Itaru E; Lv Y; Pawlik TM
Ann Surg Oncol; 2023 Mar; 30(3):1424-1433. PubMed ID: 36400889
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of prognostic factors and implication of lymph node dissection in intrahepatic cholangiocarcinoma: 10-year experience at a tertiary referral center.
Chang ME; Lei HJ; Chen MH; Yeh YC; Li CP; Hung YP; Hsia CY; Liu CA; Chau GY; Chao Y
J Chin Med Assoc; 2017 Mar; 80(3):140-146. PubMed ID: 28169208
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Value of Combined CA19-9 with Aspartate Aminotransferase to Lymphocyte Ratio in Patients with Intrahepatic Cholangiocarcinoma After Hepatectomy.
Qiu H; Liu C; Huang M; Shen S; Wang W
Cancer Manag Res; 2021; 13():5969-5980. PubMed ID: 34377017
[TBL] [Abstract][Full Text] [Related]
15. Long-term outcome and prognostic factors of combined hepatocellular carcinoma and cholangiocarcinoma after curative resection.
Jiang XX; Huang XT; Huang CS; Chen LH; Liang LJ; Yin XY
Gastroenterol Rep (Oxf); 2020 Apr; 8(2):134-142. PubMed ID: 32280473
[TBL] [Abstract][Full Text] [Related]
16. Tumor Burden Score Stratifies Prognosis of Patients With Intrahepatic Cholangiocarcinoma After Hepatic Resection: A Retrospective, Multi-Institutional Study.
Li H; Liu R; Qiu H; Huang Y; Liu W; Li J; Wu H; Wang G; Li D
Front Oncol; 2022; 12():829407. PubMed ID: 35330712
[TBL] [Abstract][Full Text] [Related]
17. Preoperative D-dimer and Gamma-Glutamyltranspeptidase Predict Major Complications and Survival in Colorectal Liver Metastases Patients After Resection.
Chen Q; Zhao H; Wu J; Cai J; Li C; Zhao J; Bi X; Li Z; Huang Z; Zhang Y; Cui W; Zhou J
Transl Oncol; 2019 Jul; 12(7):996-1004. PubMed ID: 31125760
[TBL] [Abstract][Full Text] [Related]
18. Preoperative criterion identifying a low-risk group for lymph node metastasis in intrahepatic cholangiocarcinoma.
Yoh T; Hatano E; Seo S; Terajima H; Uchida Y; Taura K; Yasuchika K; Uemoto S
J Hepatobiliary Pancreat Sci; 2018 Jun; 25(6):299-307. PubMed ID: 29656560
[TBL] [Abstract][Full Text] [Related]
19. Preoperative CEA levels are supplementary to CA19-9 levels in predicting prognosis in patients with resectable intrahepatic cholangiocarcinoma.
He C; Zhang Y; Song Y; Wang J; Xing K; Lin X; Li S
J Cancer; 2018; 9(17):3117-3128. PubMed ID: 30210635
[No Abstract] [Full Text] [Related]
20. Prognostic Impact of Preoperative Lymph Node Enlargement in Intrahepatic Cholangiocarcinoma: A Multi-Institutional Study by the Kyushu Study Group of Liver Surgery.
Adachi T; Eguchi S; Beppu T; Ueno S; Shiraishi M; Okuda K; Yamashita Y; Kondo K; Nanashima A; Ohta M; Takami Y; Noritomi T; Kitahara K; Fujioka H
Ann Surg Oncol; 2015 Jul; 22(7):2269-78. PubMed ID: 25582737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
